Picture of aap Implantate AG logo

AAQ1 aap Implantate AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Aap Implantate Q2 EBITDA Loss Of EUR 2.1 Mln

Aug 14 (Reuters) - AAP IMPLANTATE AG  AAQG.DE :
    * Q2 AND H1/2020: TANGIBLE POSITIVE IMPACT OF RESTRUCTURING
ON AAP
PERFORMANCE IN CHALLENGING COVID-19 TIMES
    * SALES OF EUR 1.9 MILLION IN Q2 OF 2020 (Q2/2019: EUR 2.5
MILLION)
    * EBITDA AT EUR -2.1 MILLION IN Q2 OF 2020 (Q2/2019: EUR
-2.1
MILLION)
    * EXPECTS SALES FOR FULL YEAR 2020 TO BE IN UPPER HALF OF
GUIDANCE
OF EUR 8 MILLION TO EUR 10 MILLION
    * EXPECTS EBITDA TO BE AT LOWER END OF GUIDANCE OF EUR -6.7
MILLION TO EUR -5.5 MILLION IN 2020
    * H1 SALES EUR 4.4 MILLION (H1/2019: EUR 6.0 MILLION)

Source text for Eikon:  ID:nEQbwy7S4a 
Further company coverage:  AAQG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on aap Implantate AG

See all news